Research and Development of a New Safe Form of Drugs - Aerosols: Measurement, Dosimetry, and Health Effects - page 281

11,63

Saline

49.4*

WF Nyc, 2 mg/kg

42*

WF, 2 mg/kg

30,03*

WF:AG, 20 mg/kg

15

WF:GA, 20 mg/kg

0 10 20 30 40 50 60

Prothrombin time (s)

FIGURE 11.23 Prothrombin time of the WF:AG (1:10). * Signiicantly different (P < 0.05) from control

(saline).

21,21

WF:AG, 20 mg/kg

WF, 2 mg/kg 21,73

0 5 10 15 20 25 30

Prothrombin time (s)

FIGURE 11.24 Prothrombin time after 48 h from single dosing of the WF:AG (1:10) and WF.

REFERENCES
Aken H.V., Bode, Ch., Darius, H. et al. 2001. State-of-the-art review: Anticoagulation: The present and future.
Clinical and Applied Thrombosis/Hemostasis , 7:195-204.
Antonova, G.F. and Tyukavkina, N.A. 1976. Synthesis of high-clean arabinogalactan from larch wood. Wood
Chemistry , 4:60.
Arifkhodzhaev, A.O. 2000. Galactans and galactan containing polysaccharides of higher plants. Chemistry of
Natural Compounds , 3:89-96.
Avgustinovich, D.F., Kovalenko, I.L., Sorokina, I.V. et al. 2003. Changes in the rats blood biochemical indices during
the experimental depression development. Bulletin of Experimental Biology and Medicine , 135(4):406-409.
Avgustinovich, D.F., Kovalenko, I.L., Sorokina, I.V. et al. 2004. Ethological study of antidepressant effect of
luaglisine in conditions of chronic social stress in mice. Bulletin of Experimental Biology and Medicine ,
137(1):99-103.
Azaz, E. and Segal, R. 1980. Glycyrrizin as gelling agent. Pharmaceutica Acta Helvetiae , 55(7):183-186.
Badykova, L.A., Mudarisova, R.H., Khamidullina, G.S. et al. 2006. Modiication of arabinogalactan and its
oxidized forms by n-aminosalicilic acid. Journal of Applied Chemistry , 79(10):1647-1649.
Badykova, L.A., Mudarisova, R.H., Tolstikova, T.G. et al. 2005. Modiication of poly- and oligosaccharides
based on arabinogalactan by 5-aminosalicilic acid. Chemistry of Natural Compounds , 3:219-222.
Baltina, L.A. 2003. Chemical modiication of glycyrrhizic acid as a route to new bioactive compounds for
medicine. Current Medicinal Chemistry , 10:155-171.
Baltina, L.A., Davydova, V.A., Boldyrev, A.V. et al. 1988. The complex compound of sodium salt of
2-[(2,6-dichlorophenyl)-amino]phenylacetic acid with glycyrrhizic acid that possesses anti-inlammatory
activity. Inventors certiicate of USSR No 1566699.
Baltina, L.A., Davydova, V.A., Boldyrev, A.V. et al. 1988. The complex compound of acetylsalicylic acid with
glycyrrhizic acid that possesses anti-inlammatory and antipyretic activity. Inventors certiicate of USSR
No 1566700.